Drobyski WR - Search Results

1

Translational Clinical Strategies for the Prevention of Gastrointestinal Tract Graft Versus Host Disease.

Rayasam A, Drobyski WR. Rayasam A, et al. Among authors: drobyski wr. Front Immunol. 2021 Nov 26;12:779076. doi: 10.3389/fimmu.2021.779076. eCollection 2021. Front Immunol. 2021. PMID: 34899738 Free PMC article. Review.

2

Inhibition of nitric oxide production is associated with enhanced weight loss, decreased survival, and impaired alloengraftment in mice undergoing graft-versus-host disease after bone marrow transplantation.

Drobyski WR, Keever CA, Hanson GA, McAuliffe T, Griffith OW. Drobyski WR, et al. Blood. 1994 Oct 1;84(7):2363-73. Blood. 1994. PMID: 7522627 Free article.

3

Effect of T-cell depletion as graft-versus-host disease prophylaxis on engraftment, relapse, and disease-free survival in unrelated marrow transplantation for chronic myelogenous leukemia.

Drobyski WR, Ash RC, Casper JT, McAuliffe T, Horowitz MM, Lawton C, Keever C, Baxter-Lowe LA, Camitta B, Garbrecht F, et al. Drobyski WR, et al. Blood. 1994 Apr 1;83(7):1980-7. Blood. 1994. PMID: 8142664 Free article.

4

Delayed infusion of normal donor cells after MHC-matched bone marrow transplantation provides an antileukemia reaction without graft-versus-host disease.

Johnson BD, Drobyski WR, Truitt RL. Johnson BD, et al. Among authors: drobyski wr. Bone Marrow Transplant. 1993 Apr;11(4):329-36. Bone Marrow Transplant. 1993. PMID: 8485480

5

Treatment of donor mice with an alpha beta T-cell receptor monoclonal antibody induces prolonged T-cell nonresponsiveness and effectively prevents lethal graft-versus-host disease in murine recipients of major histocompatibility complex (MHC)-matched and MHC-mismatched donor marrow grafts.

Drobyski WR, Majewski D. Drobyski WR, et al. Blood. 1996 Jun 15;87(12):5355-69. Blood. 1996. PMID: 8652851 Free article.

6

Ex vivo anti-CD3 antibody-activated donor T cells have a reduced ability to cause lethal murine graft-versus-host disease but retain their ability to facilitate alloengraftment.

Drobyski WR, Majewski D, Ozker K, Hanson G. Drobyski WR, et al. J Immunol. 1998 Sep 1;161(5):2610-9. J Immunol. 1998. PMID: 9725263

7

Graft-facilitating doses of ex vivo activated gammadelta T cells do not cause lethal murine graft-vs.-host disease.

Drobyski WR, Majewski D, Hanson G. Drobyski WR, et al. Biol Blood Marrow Transplant. 1999;5(4):222-30. doi: 10.1053/bbmt.1999.v5.pm10465102. Biol Blood Marrow Transplant. 1999. PMID: 10465102 Free article.

8

Evolving strategies to address adverse transplant outcomes associated with T cell depletion.

Drobyski WR. Drobyski WR. J Hematother Stem Cell Res. 2000 Jun;9(3):327-37. doi: 10.1089/15258160050079434. J Hematother Stem Cell Res. 2000. PMID: 10894354 Review.

9

Adoptively transferred gamma delta T cells indirectly regulate murine graft-versus-host reactivity following donor leukocyte infusion therapy in mice.

Drobyski WR, Vodanovic-Jankovic S, Klein J. Drobyski WR, et al. J Immunol. 2000 Aug 1;165(3):1634-40. doi: 10.4049/jimmunol.165.3.1634. J Immunol. 2000. PMID: 10903774

10

Protection from lethal murine graft-versus-host disease without compromise of alloengraftment using transgenic donor T cells expressing a thymidine kinase suicide gene.

Drobyski WR, Morse HC 3rd, Burns WH, Casper JT, Sandford G. Drobyski WR, et al. Blood. 2001 Apr 15;97(8):2506-13. doi: 10.1182/blood.v97.8.2506. Blood. 2001. PMID: 11290616 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

148 results

Search Page

Filters